Cefotetan Disodium (CAS 74356-00-6) is a cornerstone in the development of potent antibacterial agents, earning its place as a vital pharmaceutical intermediate. For professionals in the pharmaceutical industry—including R&D scientists, chemists, and product development managers—understanding its pharmacological profile is essential for effective utilization and procurement.

As a semisynthetic cephamycin antibiotic, Cefotetan Disodium's primary mechanism of action is the inhibition of bacterial cell wall synthesis. It achieves this by interfering with penicillin-binding proteins (PBPs), which are crucial for the final cross-linking of peptidoglycans—the essential structural component of bacterial cell walls. This disruption compromises cell wall integrity, leading to bacterial lysis and death. This bactericidal action is effective against a broad spectrum of microorganisms.

The spectrum of activity for Cefotetan Disodium is notable for its broad range, encompassing both Gram-positive and Gram-negative bacteria. Crucially, it exhibits enhanced activity against anaerobic bacteria, a characteristic that differentiates it from many other cephalosporins. This makes it an invaluable intermediate for synthesizing antibiotics designed to combat mixed aerobic and anaerobic infections, common in areas like intra-abdominal infections and gynecologic infections.

Pharmacologically, Cefotetan Disodium is designed for parenteral administration (intravenous or intramuscular). Following administration, it achieves high plasma concentrations rapidly, ensuring effective therapeutic levels reach the site of infection. Its pharmacokinetic profile, characterized by significant renal excretion, means that dosage adjustments may be necessary in patients with impaired renal function. This detail is critical for formulators considering the final drug product's therapeutic use.

While Cefotetan Disodium is an intermediate, understanding its downstream pharmaceutical applications—including potential side effects like gastrointestinal disturbances, hypersensitivity reactions, and hematologic changes, as well as drug interactions (e.g., with alcohol)—provides crucial context for quality control and product development. Manufacturers supplying this intermediate must ensure it meets the purity and consistency required for these sensitive applications.

For industry professionals looking to purchase Cefotetan Disodium, engaging with a reliable manufacturer from China ensures access to a product that supports advanced antibiotic development. Our commitment to providing high-quality intermediates with detailed pharmacological information empowers your research and manufacturing endeavors.